Ambalal Sarabhai Enterprises Ltd. Share Price & Stock Analysis

Ambalal Sarabhai Enterprises Ltd. (BSE: 500009) is an Ahmedabad, Gujarat-based company in the Pharmaceuticals industry. With a market capitalisation of ₹282 Cr, it ranks #2,385 by market cap among the 6,197 Indian listed companies on FinBizNet, and #32 of 63 in Pharmaceuticals. At ₹38.23 (as of 16 Nov 2026), the share price is 23.5% below its 52-week high of ₹49.98 and 26.8% above its 52-week low of ₹30.15. The share price is down 9.0% over one year and down 8.0% over three months.

Key Metrics

Current Price₹38.23
Market Cap₹282 Cr
BSE Code500009
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryBiotechnology and Life Sciences > Pharmaceuticals
P/E Ratio15.9
Return on Equity11.94%
Return on Assets4.30%
52-Week Range₹30.15 – ₹49.98
1-Year Price Change-9.0%
3-Month Price Change-8.0%
Beta (1Y)0.88
HeadquartersAhmedabad, Gujarat
Websitewww.ase.life

Shareholding and Delivery

Delivery averaged 100.0% of traded volume across 15 BSE sessions (21 Oct 2026 – 13 Nov 2026).

About Ambalal Sarabhai Enterprises Ltd.

Ambalal Sarabhai Enterprises Limited, together with its subsidiaries, manufactures, markets, and supplies pharmaceutical products in India and internationally. The company offers products for oncology, infertility, and uro-gynaec areas; generic and veterinary products; antifungal active ingredient products; vitamin C coated products; and analytical, test, and measuring instruments, as well as supplies finished dosage forms and active pharmaceutical ingredients. It also provides broadcast and professional video/audio, and electronic products. Ambalal Sarabhai Enterprises Limited was incorporated in 1977 and is based in Ahmedabad, India.

Products and Services

1. Pharmaceuticals-This segment manufactures, markets, and supplies pharmaceutical products. 2. Electronics-This segment offers analytical, test, and measuring instruments. 3. Unallocable-0 4. Segment Adjustment-0

Business Segments

1. Pharmaceuticals-54.6% 2. Electronics-45.4%

Ambalal Sarabhai Enterprises Ltd. vs Peers — Pharmaceuticals

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Abbott India Ltd.₹56,531 Cr36.334.46%₹1,814 Cr-8.1%
Emcure Pharmaceuticals Ltd₹42,344 Cr47.919.57%₹2,820 Cr+73.3%
Ajanta Pharma Limited₹41,474 Cr39.425.39%₹1,794 Cr+27.8%
Piramal Pharma Ltd₹32,600 Crn/m-4.00%₹2,617 Cr+22.8%
RUBICON RESEARCH LIMITED₹28,526 Cr112.319.14%₹576 Cr+162.7%
Caplin Point Laboratories Ltdte₹18,155 Cr28.319.94%₹630 Cr+23.6%
Pfizer Ltd.₹17,811 Cr24.517.16%₹727 Cr-24.2%
Eris Lifesciences Ltd₹17,691 Cr28.318.07%₹892 Cr-17.5%
Ambalal Sarabhai Enterprises Ltd.₹282 Cr15.911.94%—-9.0%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Ambalal Sarabhai Enterprises Ltd.?

Ambalal Sarabhai Enterprises Ltd. is trading at ₹38.23, with a market capitalisation of ₹282 Cr.

Which sector does Ambalal Sarabhai Enterprises Ltd. belong to?

Ambalal Sarabhai Enterprises Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Pharmaceuticals).

What are the key financial ratios of Ambalal Sarabhai Enterprises Ltd.?

Ambalal Sarabhai Enterprises Ltd. has a P/E of 15.9 and a return on equity of 11.94%.

What is the stock symbol of Ambalal Sarabhai Enterprises Ltd.?

Ambalal Sarabhai Enterprises Ltd. is listed on the BSE under the scrip code 500009.

How has Ambalal Sarabhai Enterprises Ltd.'s share price moved over the past year?

Ambalal Sarabhai Enterprises Ltd.'s share price is down 9.0% over one year and down 8.0% over three months. Its 52-week range is ₹30.15 to ₹49.98.

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.